Literature DB >> 36258701

Polyethylene Glycol 3350 Crystal Nephropathy in Association With Glomerular Mesangial Immunoglobin A Deposition.

Rasha Aly1, Ratna Acharya2, Xu Zeng3, Kiran Upadhyay1.   

Abstract

Polyethylene glycol (PEG) 3350, an active ingredient of over-the-counter MiraLAX, is a commonly used laxative in children and is produced by polymerization of ethylene glycol (EG). Masked EG toxicity secondary to contamination of PEG 3350 could occur. We present a 7-year-old child with developmental delay who presented with altered mental status and acute kidney injury (AKI) following intake of generic PEG 3350 for few days prior to presentation. There was high anion gap metabolic acidosis, hypernatremia, elevated osmolar gap, lactic acidosis, and AKI. Urinalysis showed tubular proteinuria, microscopic hematuria, and calcium oxalate crystals. Prior urinalyses were normal without hematuria or proteinuria. Renal biopsy revealed evidence of mesangial dominant immunoglobulin A (IgA) and complement 3 (C3) deposits along with dense tubular deposition of calcium oxalate crystals. He subsequently developed worsening oliguric AKI and required hemodialysis (HD) for several sessions. The AKI resolved within 2 weeks and further HD was not required. Mental status improved in few days. Follow-up urinalyses showed resolution of microscopic hematuria and crystalluria. We hypothesized that the generic PEG 3350 most likely was contaminated with EG leading to the presentation. A high index of suspicion of contamination of PEG 3350 with EG is required in patients presenting with unexplained high anion gap metabolic acidosis, elevated osmolar gap, lactic acidosis, AKI, calcium oxalate crystalluria, and oxalate crystals on renal biopsy. Further studies are needed to determine whether there is an association between transient glomerular mesangial IgA deposition and crystal nephropathy. Copyright 2022, Aly et al.

Entities:  

Keywords:  Acute kidney injury; IgA; Mesangial; Oxalate; Polyethylene glycol 3350

Year:  2022        PMID: 36258701      PMCID: PMC9534199          DOI: 10.14740/jmc4000

Source DB:  PubMed          Journal:  J Med Cases        ISSN: 1923-4155


  24 in total

1.  Incidence of latent mesangial IgA deposition in renal allograft donors in Japan.

Authors:  Koichi Suzuki; Kazuho Honda; Kazunari Tanabe; Hiroshi Toma; Hiroshi Nihei; Yutaka Yamaguchi
Journal:  Kidney Int       Date:  2003-06       Impact factor: 10.612

2.  Early and late presentations of ethylene glycol poisoning.

Authors:  Stephen M S Ting; Irene Ching; Harikrishnan Nair; Gerald Langman; Vijayan Suresh; R Mark Temple
Journal:  Am J Kidney Dis       Date:  2009-03-09       Impact factor: 8.860

3.  American Gastroenterological Association medical position statement on constipation.

Authors:  Adil E Bharucha; Spencer D Dorn; Anthony Lembo; Amanda Pressman
Journal:  Gastroenterology       Date:  2013-01       Impact factor: 22.682

Review 4.  Crystal nephropathies: mechanisms of crystal-induced kidney injury.

Authors:  Shrikant R Mulay; Hans-Joachim Anders
Journal:  Nat Rev Nephrol       Date:  2017-02-20       Impact factor: 28.314

5.  Transient IgA nephropathy with acute kidney injury in a patient with dengue fever.

Authors:  Bala Krishna Upadhaya; Alok Sharma; Ambar Khaira; Amit K Dinda; Sanjay K Agarwal; Suresh C Tiwari
Journal:  Saudi J Kidney Dis Transpl       Date:  2010-05

6.  Polyethylene glycol as a non-absorbable prokinetic agent in the lower gastrointestinal tract.

Authors:  M Tonini
Journal:  Ital J Gastroenterol Hepatol       Date:  1999-11

7.  Calcium oxalate monohydrate, a metabolite of ethylene glycol, is toxic for rat renal mitochondrial function.

Authors:  Kenneth E McMartin; Kendall B Wallace
Journal:  Toxicol Sci       Date:  2004-12-15       Impact factor: 4.849

Review 8.  Recent advances in the physiopathology of IgA nephropathy.

Authors:  Renato C Monteiro
Journal:  Nephrol Ther       Date:  2018-04       Impact factor: 0.722

Review 9.  Intestinal microbiota and chronic constipation.

Authors:  Ying Zhao; Yan-Bo Yu
Journal:  Springerplus       Date:  2016-07-19

10.  Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro.

Authors:  Barry W Neun; Yechezkel Barenholz; Janos Szebeni; Marina A Dobrovolskaia
Journal:  Molecules       Date:  2018-07-12       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.